Rong Xue-dong, Liu Wei-juan, Guo Xin-mei
Shandong Provincial Chest Hospital, Jinan.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Oct;27(10):922-4.
To evaluate the clinical efficacy of Xiaoshui Powder as auxiliary with chemotherapy for treatment of tuberculous remnant pleural effusion.
Sixty patients were assigned to the treated group and the control group, 30 in each group. All were given conventional treatment but those in the treated group were given Xiaoshui Powder additionally. The hydrothorax disappearance time, and change of vital capacity of lung and immune function in patients were observed.
Hydrothorax disappearance time in all the 30 patients of the treated group was 26.0 +/- 3.8 days in average, while in the control group, it only disappeared in 23 with the mean disappearance time prolonged to 42.0 +/- 1.2 days, showing significant difference between the two groups (P<0.05). The improvement of pulmonary vital capacity and immune function in the treated group were superior to those in the control group (P <0.05).
Xiaoshui Powder has definitely curative effect for auxiliary treatment of tuberculous remnant pleural effusion.
评价消水散辅助化疗治疗结核性残留胸腔积液的临床疗效。
将60例患者分为治疗组和对照组,每组30例。两组均给予常规治疗,但治疗组额外给予消水散。观察患者胸腔积液消失时间、肺活量及免疫功能变化。
治疗组30例患者胸腔积液平均消失时间为26.0±3.8天,对照组仅23例胸腔积液消失,平均消失时间延长至42.0±1.2天,两组差异有统计学意义(P<0.05)。治疗组肺通气量和免疫功能的改善优于对照组(P<0.05)。
消水散辅助治疗结核性残留胸腔积液有确切疗效。